Federal award
MEDITRADE MEDICAL TRADING GMBH
W9114F23P0001
Contract
Obligated and Ceiling
- Obligated (net)
- $919,544.70
- Ceiling (potential value, not spending)
- $919,544.70
- Current value
- $919,544.70
- Gross positive obligations
- $2,816,806.43
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- MEDITRADE MEDICAL TRADING GMBH · FZF7KMCH21Q8
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- MEDITRADE MEDICAL TRADING GMBH · FZF7KMCH21Q8
- Awarding agency
- Department of War · sub-agency 2100 · office W9114F
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W9114F23P0001
- Award type code
- B
- Actions
- 8 · Dec 8, 2022 to Aug 28, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History8
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Aug 28, 2025 | FY2025 | P00007 | B | −$121,101.23 | — |
| Nov 14, 2024 | FY2025 | P00006 | B | $301,495.28 | — |
| Apr 11, 2024 | FY2024 | P00005 | B | −$728,674.22 | — |
| Feb 7, 2024 | FY2024 | P00004 | B | −$1,045,982.12 | — |
| Dec 6, 2023 | FY2024 | P00003 | C | $1,159,601.97 | — |
| Nov 16, 2023 | FY2024 | P00002 | G | $0.00 | — |
| Jul 7, 2023 | FY2023 | P00001 | B | −$1,504.16 | — |
| Dec 8, 2022 | FY2023 | 0 | — | $1,355,709.18 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.